ସ୍ତନ କ୍ୟାନ୍ସର

The Nanosomal Docetaxel Lipid Suspension (NDLS) consists of uniformly sized micro particles of docetaxel suspended in a lipid based formulation. The advantage of such a Lipid Based formulation of Docetaxel is an improvement of the safety profile by eliminating excipients, polysorbate 80 and ethanol which are present in conventional Docetaxel formulations (Taxotere®). This randomized, open-label study is designed to assess the efficacy and safety of Nanosomal Docetaxel Lipid Suspension at the dose of 75 mg/m2 and at the dose of 100 mg/m2 compared to Taxotere® at the dose of 100 mg/m2 in triple-…

ସ୍ପୋନ୍ସର: ଜିନ ଫାର୍ମାସ୍ୟୁଟିକାଲ୍ସ ଇନ୍‌କ୍.
କ୍ଲିନିକାଲ୍ ଟ୍ରାଏଲ୍ସ.gov ରେ NCT03671044
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 21 ମାର୍ଚ୍ଚ 2025 · ଆମ ଦ୍ୱାରା 20 ଅକ୍ଟୋବର 2026 ରେ ପଢାଯାଇଛି